skip to content

Market News

UDG notes Sharp's expansion in US, UK capacity

03 April 2017 07:18

Healthcare services provider UDG Healthcare has confirmed capacity expansion projects in the US and UK by its division Sharp Packaging Services.

In the US, Sharp had bought a 146,000 sq ft pharmaceutical packaging facility in Bethlehem, Pennsylvania, US from Daiichi Sankyo Inc. (DSI) for a total of $14m, including all equipment and employees.

The facility was FDA approved and included four packaging equipment lines, cold and frozen storage, office space, warehousing and an analytical laboratory.

As part of the transaction, DSI would also become a commercial and clinical client, with Sharp providing packaging services for a number of their US branded products and clinical trial activity.

This acquisition was expected to have an immaterial impact on FY 2017 profitability.

In the UK, Sharp had announced a £9m investment in a new facility in Rhymney, South Wales for its clinical packaging business.

"The initial phase of the expansion, which is expected to be completed by late 2018, will involve the acquisition and renovation of a 110,000 sq ft facility within the site, more than triple the size of the current UK facility," the company said.

Initially 75,000 sq ft would be fitted out. The site also benefited from the potential for further significant capacity expansion.

Story provided by

Related Company: UDG

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?


Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.